✦ LIBER ✦

Effects of solanezumab versus placebo administration on biomarkers in people with mild-to-moderate Alzheimer's disease: Results from two phase III clinical trials

✍ Scribed by Dean, Robert; Siemers, Eric; Carlson, Christopher; Estergard, Wahiba; Sundell, Karen; Henley, David; Hake, Ann; Eads, Jennifer; Sexton, Cora; Liu-Seifert, Hong; Sethuraman, Gopalan; Chen, Yun-Fei; Gonzales, Celedon; Lachno, D. Richard; Gelfanova, Valentina; Talbot, Jayne; Racke, Margaret; Mintun, Mark; Pontecorvo, Michael; Willis, Brian; DeMattos, Ronald; Mohs, Richard

Book ID: 121885744
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 56 KB
Volume: 9
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2013.05.568

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence and clinical progression of pl

Incidence and clinical progression of placebo-treated amyloid-negative subjects with mild-to-moderate Alzheimer's disease (AD): Results from the phase III PET substudies of bapineuzumab and solanezumab

✍ Salloway, Stephen; Sperling, Reisa; Gregg, Keith; Yu, Peng; Joshi, Abhinay; Lu, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Correlation of brain atrophy with clinic

Correlation of brain atrophy with clinical progression in mild-to-moderate Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab

✍ Novak, Gerald; Einstein, Steven; Lu, Yuan; Tudor, Iulia Cristina; Gregg, Keith; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Results from CONNECTION: A global, Phase

Results from CONNECTION: A global, Phase 3 double-blind, placebo-controlled confirmatory trial of dimebon (latrepirdine) in patients with mild-to-moderate Alzheimer's disease

✍ Rachelle S. Doody; Pierre Tariot; Jeff Cummings; Bengt Winblad; Bryan Selby; And 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Effect of bapineuzumab on CSF p-tau and

Effect of bapineuzumab on CSF p-tau and t-tau in mild-to-moderate Alzheimer's disease: Results from two phase III trials in APOE-ε4 carriers and noncarriers

✍ Streffer, Johannes; Blennow, Kaj; Salloway, Stephen; Zetterberg, Henrik; Xu, Yi- 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 56 KB

P.4.044 Long-term efficacy of donepezil

P.4.044 Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study

✍ B. Winblad; A. Wimo; A.-L. Wetterholm; A. Haglund; K. Engedal; H. Soininen; F.R. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 144 KB